GalaGen Inc. – Trademark Portfolio
Entity Type: 03
GalaGen Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include L-EMENTAL. The owner is based in Arden Hills, MN.
4001 Lexington Avenue North
Arden Hills, MN 55126
Showing of trademarks Trademarks
Trademark Classifications
GalaGen Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does GalaGen Inc. have?
GalaGen Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 1 registered, 10 abandoned, 6 cancelled.
What trademark classes does GalaGen Inc. file in?
GalaGen Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 16 (Paper Goods), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GalaGen Inc.'s most well-known trademarks?
GalaGen Inc.'s registered trademark portfolio includes well-known marks such as L-EMENTAL. These are among 1 currently registered trademark in the portfolio.
What is GalaGen Inc.'s trademark registration success rate?
GalaGen Inc. has a 6% trademark registration rate, with 1 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.